Chromadex Corp (NASDAQ:CDXC) currently has a daily average trading volume of 1.18M but it saw 1389684 shares traded in last market. With a market cap of 508.72M USD, the company’s current market price of $6.66 came falling about -11.55 while comparing to the previous closing price of $7.53. In past 52 weeks, the stock remained buoying in the range of price level as high as $7.97 and as low as $1.32. In the recent trading on the day, stock has struck highest price mark of $6.625 while lowest mark touched by it was $7.49.
Taking a look at 20-day trading activity of Chromadex Corp (CDXC) gives us an average price of $7.28, while its current price level is -16.48% below from 52-week high level whereas it is 404.55% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $5.23 while that of 200 days or SMA-200 reads an average of $3.61. A closer look into the stock’s movement over the week reveals that its volatility is standing at 6.08% during that period while stretching the period over a month that increases to 7.20%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 50.44 which implies that the stock is in neutral territory.
B. Riley Securities downgraded its recommendation for the stock as a “Neutral” from “Buy” on August 11, 2022 while assigning a price target range of $6-$2.40. ROTH Capital issued its recommendations for the stock as it initiated the price target for the stock is $7.
Over the week, CDXC’s stock price is moving -12.83% down while it is 9.00% when we observe its performance for the past one month. Year-to-date it is 365.73% up and over the past year, the stock is showing an upside performance of 365.73%.
Currently, Chromadex Corp’s total number of outstanding shares is 76.03M. Company’s return on investment (ROI) stands at 4.10% and return on equity (ROE) at 4.82%. It has a price to earnings ratio (P/E ratio) of 352.38 while having a 50.26 of forward P/E ratio. Stock’s beta reads 2.15. Stock has a price to book (P/B) ratio of 14.73 while price to sale or P/S ratio amounts to 5.55. Its return on asset (ROA) is 2.70% on average.
